Allison Montoya

Crizotinib has Preclinical Efficacy in Philadelphia-negative Myeloproliferative Neoplasms.

B. Halmos, R. Okabe, K. Ames, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.